A Resource for Healthcare and Social Services Professionals
This 8-hour course prepares nurses and other medical staff to manage office-based addiction treatment with buprenorphine and naltrexone.
PLEASE READ THIS TRAINING ANNOUNCEMENT IN FULL
There will be 1 hour of pre-work for this course that provides the foundation for the training. It is strongly recommended that you complete this pre-work so that you are adequately prepared for the course. Please see below for additional information about the pre-work.
If you have questions related to the pre-work, please contact Shereen Sodder at firstname.lastname@example.org or 617-414-6659
This course will prepare nurses and other key members of the multidisciplinary care team to deliver medication for addiction treatment (MAT), such as buprenorphine and naltrexone, using a chronic care management model. Topics covered will include the science of addiction as a brain disorder, the pharmacotherapy of medications used to treat opioid and alcohol use disorders (current standard of care), and practical tools for implementing these treatment modalities into an office-based setting and for supporting physicians or other clinicians as part of a care team. Attendees will learn to screen patients for substance use disorders, initiate medication, and provide ongoing care and counseling. Check-in for the course will be from 8:00 AM to 8:30 AM and the training will run from 8:30 AM to 4:30 PM.
For this training, there is pre-work that we are requesting participants complete in advance. For all attendees, we strongly recommend completing the pre-work. The pre-work is the foundation for the work we will do together at the training; we cannot stress enough the importance of reviewing the material ahead of time. There are two options for completing the pre-work:
A light breakfast and lunch will be provided. If you have dietary restrictions please feel free to let us know and we will do our best to accommodate them.
Parking validation will be provided.
This is an in-person training. There will not be an option to attend via webinar
The learner will: Define opioid use disorder; Explain methods used to evaluate patients for treatment with buprenorphine and injectable naltrexone; Identify the clinically relevant pharmacological characteristics of buprenorphine and buprenorphine/naloxone; and Outline tools for monitoring and supporting patients engaged in Medication for Addiction Treatment (MAT).
Nurses and other clinical staff providing treatment for substance use disorders in an office-based setting.
Boston Medical Center Grayken Center for Addiction, Department of Public Health, Bureau of Addiction Services
Boston Medical Center grants 7.7 hours to all RNS who attend, complete the evaluation, and complete the post test. Boston Medical Center is an approved provider of continuing nursing education by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.